Overview/reflections on the 2009 H1N1 pandemic
Authors:
- Surinder PadaSPSurinder Pada
- Paul A. TambyahPTPaul A. Tambyah
- 1 May 2011
- journal article
- research article
- Published by Elsevier in Microbes and Infection
- Vol. 13 (5) , 470-478
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Emergence of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus within 48 HoursEmerging Infectious Diseases, 2010
- All-Cause Mortality during First Wave of Pandemic (H1N1) 2009, New South Wales, Australia, 2009Emerging Infectious Diseases, 2010
- Cross-Reactive Antibodies to Pandemic (H1N1) 2009 Virus, SingaporeEmerging Infectious Diseases, 2010
- Clinical Findings and Demographic Factors Associated With ICU Admission in Utah Due to Novel 2009 Influenza A(H1N1) InfectionChest, 2010
- Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In VitroPLOS ONE, 2010
- Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trialThe Lancet, 2010
- Pandemic Potential of a Strain of Influenza A (H1N1): Early FindingsScience, 2009
- Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza PreparednessThe Journal of Infectious Diseases, 2008
- Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A virusesAntiviral Research, 2008
- Influenza RevisitedEmerging Infectious Diseases, 2006